glucuronic acid has been researched along with Crohn Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anba-Mondoloni, J; Gloux, K | 1 |
| Amre, D; Chen, H; Das, SK; Halim, T; Haque, T; Jones, ML; Metz, T; Mirzaei, M; Prakash, S | 1 |
| Acartürk, F; Konuş-Boyunağa, O; Takka, S; Tuğcu-Demiröz, F | 1 |
3 other study(ies) available for glucuronic acid and Crohn Disease
| Article | Year |
|---|---|
Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
Topics: Adult; Amino Acid Motifs; Bacterial Proteins; Case-Control Studies; Crohn Disease; Dysbiosis; Escherichia coli; Eubacterium; Family; Female; Firmicutes; Gastrointestinal Microbiome; Genetic Loci; Glucuronic Acid; Glucuronidase; Glucuronides; Humans; Male; Membrane Transport Proteins; Molecular Sequence Data; Phylogeny; Plasmids; Risk Factors; Sequence Alignment | 2016 |
A new method for targeted drug delivery using polymeric microcapsules: implications for treatment of Crohn's disease.
Topics: Alginates; Animals; Coated Materials, Biocompatible; Crohn Disease; Diffusion; Drug Carriers; Drug Delivery Systems; Gastrointestinal Contents; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Intestines; Materials Testing; Microspheres; Particle Size; Polylysine; Thalidomide | 2005 |
Evaluation of alginate based mesalazine tablets for intestinal drug delivery.
Topics: Alginates; Biocompatible Materials; Crohn Disease; Drug Delivery Systems; Gels; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Ileum; Intestine, Large; Intestines; Mesalamine; Polymers; Tablets; Time Factors; X-Rays | 2007 |